{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:09:06Z","timestamp":1783346946008,"version":"3.54.6"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.euroneuro.2009.09.002","type":"journal-article","created":{"date-parts":[[2009,10,30]],"date-time":"2009-10-30T08:37:22Z","timestamp":1256891842000},"page":"187-194","source":"Crossref","is-referenced-by-count":36,"title":["Effects of repeated risperidone exposure on serotonin receptor subtypes in developing rats"],"prefix":"10.1016","volume":"20","author":[{"given":"Yong Kee","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Moran-Gates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank I.","family":"Tarazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2009.09.002_bib1","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1097\/00004583-199510000-00012","article-title":"Childhood-onset schizophrenia: the severity of premorbid course","volume":"34","author":"Alaghband-Rad","year":"1995","journal-title":"J. Am. Acad. Child Adolesc. Psych."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib2","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/00004583-199705000-00021","article-title":"Risperidone in adolescents with schizophrenia: an open pilot study","volume":"36","author":"Armenteros","year":"1997","journal-title":"J. Am. Acad. Child Adolesc. Psych."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0893-133X(97)00112-7","article-title":"Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence","volume":"18","author":"Arnt","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2009.09.002_bib4","series-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","first-page":"461","article-title":"Pharmacotherapy of psychosis and mania","author":"Baldessarini","year":"2005"},{"key":"10.1016\/j.euroneuro.2009.09.002_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/026988110201600113","article-title":"A systematic review of the use of atypical antipsychotics in autism","volume":"16","author":"Barnard","year":"2002","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0304-3940(91)90787-T","article-title":"Fetal human brain exhibits a prenatal peak in the density of serotonin 5-HT1A receptors","volume":"127","author":"Bar-Peled","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib7","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0193-953X(18)30657-9","article-title":"Childhood schizophrenia. A review and comparison with adult-onset schizophrenia","volume":"8","author":"Beitchman","year":"1985","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4088\/JCP.v62n0111","article-title":"Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study","volume":"62","author":"Bruggeman","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2009.09.002_bib9","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0893-133X(96)00053-X","article-title":"5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia","volume":"15","author":"Burnet","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2009.09.002_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0893-133X(94)00129-N","article-title":"Radioreceptor binding profile of the atypical antipsychotic olanzapine","volume":"14","author":"Bymaster","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2009.09.002_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.euroneuro.2008.08.010","article-title":"Effects of risperidone on glutamate receptor subtypes in developing rat brain","volume":"19","author":"Choi","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0736-5748(87)90027-X","article-title":"Transient expression of 5-HT1A receptor binding sites in some areas of the rat CNS during postnatal development","volume":"5","author":"Daval","year":"1987","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib13","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1586\/14737175.5.6.713","article-title":"Risperidone in pervasive developmental disorders","volume":"5","author":"Erickson","year":"2005","journal-title":"Expert Rev. Neurother."},{"issue":"Suppl 6","key":"10.1016\/j.euroneuro.2009.09.002_bib14","first-page":"30","article-title":"Atypical antipsychotics in the treatment of children and adolescents: clinical applications","volume":"65","author":"Findling","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2009.09.002_bib15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-3565(24)36475-4","article-title":"Dopamine receptor subtypes: differential regulation after 8months treatment with antipsychotic drugs","volume":"280","author":"Florijn","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib16","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0022-3565(25)11149-X","article-title":"5-Hydroxytryptamine-1A but not 5-hydroxytryptamine-2 receptors are enriched on neocortical pyramidal neurons destroyed by intrastriatal volkensin","volume":"261","author":"Francis","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00004714-200302000-00012","article-title":"Clozapine pharmacokinetics in children and adolescents with childhood-onset schizophrenia","volume":"23","author":"Frazier","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib18","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.bi.56.070187.003151","article-title":"G proteins: transducers of receptor-generated signals","volume":"56","author":"Gilman","year":"1987","journal-title":"Ann. Rev. Biochem."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib19","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/schbul\/20.4.697","article-title":"Childhood-onset schizophrenia: an NIMH study in progress","volume":"20","author":"Gordon","year":"1994","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib20","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0361-9230(01)00623-2","article-title":"Paradoxical trafficking and regulation of 5-HT2A receptors by agonists and antagonists","volume":"56","author":"Gray","year":"2001","journal-title":"Brain. Res. Bull."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/cap.1996.6.251","article-title":"Risperidone in the treatment of children and adolescents with schizophrenia: a retrospective study","volume":"6","author":"Grcevich","year":"1996","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib22","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/00004583-199209000-00027","article-title":"Schizophrenia with childhood onset: a phenomenological study of 38 cases","volume":"31","author":"Green","year":"1992","journal-title":"J. Am. Acad. Child Adolesc. Psych."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib23","series-title":"Econometric Analysis","first-page":"462","author":"Greene","year":"2000"},{"key":"10.1016\/j.euroneuro.2009.09.002_bib24","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00004714-200004000-00015","article-title":"Olanzapine pharmacokinetics in pediatric and adolescent inpatients with childhood-onset schizophrenia","volume":"20","author":"Grothe","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib25","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1007\/BF02245005","article-title":"Differential changes in serotonin 5-HT1A and 5-HT2 receptor binding in patients with chronic schizophrenia","volume":"112","author":"Hashimoto","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2009.09.002_bib26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00213-003-1549-0","article-title":"The 5-HT2A receptor antagonist M100, 907 attenuates motor and \u2018impulsive-type\u2019 behaviors produced by NMDA receptor antagonism","volume":"170","author":"Higgins","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2009.09.002_bib27","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1046\/j.1471-4159.2001.00154.x","article-title":"5-HT2A and D2 receptor blockade increases cortical DA release via 5-HT1A receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release","volume":"76","author":"Ichikawa","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1017\/S002196309700173X","article-title":"Childhood-onset schizophrenia: implications of clinical and neurobiological research","volume":"39","author":"Jacobsen","year":"1998","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2009.09.002_bib29","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib30","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF02090784","article-title":"S(+)-Aporphines are not selective for human D3 dopamine receptors","volume":"14","author":"Kula","year":"1994","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0893-133X(95)00049-J","article-title":"Differential regulation of rat 5-HT2A and 5-HT2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotic drugs","volume":"13","author":"Kuoppamaki","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2009.09.002_bib32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s007020050024","article-title":"Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D2 and serotonin 5-HT2A receptors in the rat brain","volume":"107","author":"Kusumi","year":"2000","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0026-895X(25)14623-3","article-title":"[3H]ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role","volume":"21","author":"Leysen","year":"1982","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib34","first-page":"S20","article-title":"Treatment challenges and safety considerations for antipsychotic use in children and adolescents with psychoses","volume":"65","author":"McConville","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2009.09.002_bib35","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa013171","article-title":"Risperidone in children with autism and serious behavioral problems","volume":"347","author":"McCracken","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib36","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0022-3565(24)38982-7","article-title":"Improving the treatment of schizophrenia: focus on serotonin 5-HT1A receptors","volume":"295","author":"Millan","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib37","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.euroneuro.2006.10.004","article-title":"Effects of risperidone on dopamine receptor subtypes in developing rat brain","volume":"17","author":"Moran-Gates","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib38","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0006-3223(99)00231-0","article-title":"Childhood-onset schizophrenia: rare but worth studying","volume":"46","author":"Nicolson","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2009.09.002_bib39","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1176\/ajp.156.10.1575","article-title":"Clinical and neurobiological correlates of cytogenetic abnormalities in childhood-onset schizophrenia","volume":"156","author":"Nicolson","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2009.09.002_bib40","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/syn.890060205","article-title":"Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain","volume":"6","author":"O'Dell","year":"1990","journal-title":"Synapse"},{"key":"10.1016\/j.euroneuro.2009.09.002_bib41","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1982"},{"key":"10.1016\/j.euroneuro.2009.09.002_bib42","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-8993(85)90856-X","article-title":"Quantitative autoradiographic mapping of serotonin receptors in rat brain. I. Serotonin-1 receptors","volume":"346","author":"Pazos","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib43","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/cap.1997.7.167","article-title":"Risperidone in children and adolescents with pervasive developmental disorder: pilot trial and follow-up","volume":"7","author":"Perry","year":"1997","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib44","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1523\/JNEUROSCI.12-02-00440.1992","article-title":"Distribution and cellular localization of messenger RNA coding for 5-HT1A receptor in the rat brain\u2014correlation with receptor binding","volume":"12","author":"Pompeiano","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib45","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00004583-198905000-00017","article-title":"The phenomenology of schizophrenia occurring in childhood","volume":"28","author":"Russell","year":"1989","journal-title":"J. Am. Acad. Child Adolesc. Psych."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib46","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2009.09.002_bib47","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0006-3223(95)00026-7","article-title":"Autoradiography with [3H]8-OH-DPAT reveals increases in 5-HT1A receptors in ventral prefrontal cortex in schizophrenia","volume":"39","author":"Simpson","year":"1996","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2009.09.002_bib48","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/schbul\/20.4.713","article-title":"Children with schizophrenia: diagnosis, phenomenology, and pharmacotherapy","volume":"20","author":"Spencer","year":"1994","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib49","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0006-8993(95)01361-X","article-title":"Serotonin1A receptors are increased in postmortem prefrontal cortex in schizophrenia","volume":"708","author":"Sumiyoshi","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib50","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00213-002-1016-3","article-title":"Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions","volume":"161","author":"Tarazi","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.euroneuro.2009.09.002_bib51","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/00023210-200216010-00003","article-title":"Effects of newer antipsychotics on extrapyramidal function","volume":"16","author":"Tarsy","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.euroneuro.2009.09.002_bib52","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0026-895X(25)08646-8","article-title":"Molecular determinants for recognition of RU 24969 analogs at central 5-hydroxytryptamine recognition sites: use of a bilinear function and substituent volumes to describe steric fit","volume":"34","author":"Taylor","year":"1988","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib53","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0026-895X(25)09516-1","article-title":"4-[125I]iodo-(2, 5-dimethoxy)phenyl-isopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5-HT2) receptors in mammalian cells transfected with a rat 5-HT2 cDNA: evidence for multiple states and not multiple 5-HT2 receptor subtypes","volume":"38","author":"Teitler","year":"1990","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.euroneuro.2009.09.002_bib54","series-title":"Schizophrenia and Mood Disorders","first-page":"1","article-title":"Comparative pharmacology of classical and novel (second-generation) antipsychotics","author":"Waddington","year":"2000"},{"key":"10.1016\/j.euroneuro.2009.09.002_bib55","series-title":"Statistical Principles in Experimental Design","first-page":"165","author":"Winer","year":"1991"},{"key":"10.1016\/j.euroneuro.2009.09.002_bib56","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/cne.903510304","article-title":"Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain","volume":"351","author":"Wright","year":"1995","journal-title":"J. Comp. Neurol."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X09002326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X09002326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:34:08Z","timestamp":1739406848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X09002326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0924977X09002326"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2009.09.002","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}